Intellia Therapeutics (NTLA US)

Analysis

Health Care • United States

Intellia Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the research and clinical development of gene editing therapies for patients with genetically-based diseases.

Refresh

Company Event • 27 Feb 2026 01:30 • Upcoming

Add To Calendar

Q4 2025

Company Event • 06 Nov 2025 22:30 • Upcoming

Add To Calendar

Q3 2025

Company Event • 27 Oct 2025 20:30 • Latest

Study Update

Company Event • 30 Sep 2025 19:00 • Upcoming

Add To Calendar

Company Presentation

Company Event • 07 Aug 2025 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Q4 2025

Q3 2025

Study Update

Company Presentation

Q2 2025